Search

Your search keyword '"FitzGerald, J. Mark"' showing total 1,455 results

Search Constraints

Start Over You searched for: Author "FitzGerald, J. Mark" Remove constraint Author: "FitzGerald, J. Mark"
1,455 results on '"FitzGerald, J. Mark"'

Search Results

2. Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation

3. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

5. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

6. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

7. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

8. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

9. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

10. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study

11. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial

12. Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap

13. Impaired Sleep Quality in COPD Is Associated With Exacerbations The CanCOLD Cohort Study

15. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

19. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

20. Disease burden in individuals with symptomatic undiagnosed asthma or COPD

21. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

24. Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study

26. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

27. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

30. Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry

32. Potential Severe Asthma Hidden in UK Primary Care

33. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

35. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

39. Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis

42. International Severe Asthma Registry: Mission Statement

44. Normative Reference Equations for Breathlessness Intensity during Incremental Cardiopulmonary Cycle Exercise Testing

45. Opportunities to improve asthma and COPD prevention and care: insights from the patient journey obtained through focus groups

46. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

47. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

Catalog

Books, media, physical & digital resources